Friday, May 10, 2024

Select Subcommittee On The Coronavirus Pandemic Goes RICO

Today, Select Subcommittee on the Coronavirus Pandemic Chairman Brad Wenstrup announced a subpoena to compel Dr. David Morens - a top advisor to Dr. Anthony Fauci at the National Institute of Allergy and Infectious Diseases - to appear for a public hearing on May 22, 2024.

Only two days later, on April 22, 2024, Dr. Morens's attorney followed this exact plan and told Select Subcommittee staff that Dr. Morens was "Unavailable" to appear for a public hearing on the offered date of May 7, 2024.

The attorney provided four alternative dates - all of which Dr. Morens and his team seemingly understood to be unacceptable given the public Congressional and Select Subcommittee schedule.

Dr. Morens's evasion of public testimony "Appears to be a poorly veiled attempt to protect Dr. Fauci, insulate him from the actions the Select Subcommittee is investigating, and obstruct the Select Subcommittee's investigation," wrote Chairman Wenstrup in a subpoena cover letter to Dr. Morens.

In June 2023, the Select Subcommittee released a batch of emails in which Dr. Morens appears to hide COVID-19 information.

After receiving a letter from the Select Subcommittee detailing Dr. Morens's potential federal records violation, the NIH placed him on administrative leave.

In April 2024, the Select Subcommittee revealed new information from a whistleblower that appeared to provide further evidence of Dr. Morens intentionally subverting federal transparency laws to shield discussions related to the origins of COVID-19. 

https://rwmalonemd.substack.com/p/select-subcommittee-on-the-coronavirus?utm_source=post-email-title&publication_id=583200&post_id=144474953&utm_campaign=email-post-title&isFreemail=true&r=1mr4m3&triedRedirect=true&utm_medium=email 

No comments:

Post a Comment

Senate Democrats Downplay Complication And Abuse Risks Linked To Mail-Order Mifepristone

In a recent Senate hearing titled "Protecting Women: Exposing the Dangers of Chemical Abortion Drugs," Senate Democrats faced crit...